Primary Hyperparathyroidism Masquerading as Acute Pancreatitis

Abstract

Acute pancreatitis as an initial manifestation of primary hyperparathyroidism (PHPT) is a rare occurrence and timely diagnosis of PHPT is crucial in preventing repeat attack of pancreatitis. The study aimed at evaluating the clinico-radiological profile of patients admitted with acute pancreatitis as the index presentation of PHPT and to determine the factors associated with development of severe pancreatitis. This series included retrospective analysis of medical records of 30 patients admitted with acute pancreatitis as initial manifestation of PHPT. Additionally, we analyzed the data of another 30 patients admitted with PHPT but without any evidence of pancreatitis, to serve as control group. The mean age of the subjects was 44.9±13.9 years with male to female ratio of 1.30. The mean serum calcium level was 12.24±2.79 mg/dl and five (16.6%) patients had normocalcemia at time of presentation. Presence of nephrolithiasis was significantly associated with severe pancreatitis. One patient had refractory hypercalcemia associated with renal failure and was successfully managed with denosumab. Patients with PHPT associated with acute pancreatitis had significantly higher calcium levels and lower frequency of skeletal involvement as compared to PHPT patients without pancreatitis. PHPT masquerading as acute pancreatitis is rare and high index of suspicion is required to diagnose this condition especially in the presence of normocalcemia at presentation. Patients with PHPT associated pancreatitis had male preponderance, higher calcium levels, and lower frequency of skeletal involvement as compared to PHPT patients without pancreatitis.

Key words

hyperparathyroidism - acute pancreatitis - hemodialysis - nephrolithiasis - refractory hypercalcemia

Publication History

Received: 24 January 2021

Accepted after revision: 26 April 2021

Article published online:
21 June 2021

• References

• 1 Smith FB, Cook RT. Acute fatal hyperparathyroidism. Lancet 1940; 2: 650
• 2 Khoo TK, Vege SS, Abu-Lebdeh HS. et al. Acute pancreatitis in primary hyperparathyroidism: A population-based study. J Clin Endocrinol Metab 2009; 94: 2115-2118
• 3 Felderbauer P, Karakas E, Fendrich V. et al. Multifactorial genesis of pancreatitis in primary hyperparathyroidism: Evidence for “protective” (PRSS2) and “destructive” (CTRC) genetic factors. Exp Clin Endocrinol Diabetes 2011; 119: 26-29
• 4 Bhadada SK, Udawat HP, Bhansali A. et al. Chronic pancreatitis in primary hyperparathyroidism: Comparison with alcoholic and idiopathic chronic pancreatitis. J Gastroenterol Hepatol 2008; 23: 959-964
• 5 Bai HX, Giefer M, Patel M. et al. The association of primary hyperparathyroidism with pancreatitis. J Clin Gastroenterol 2012; 46: 656-661
• 6 Haverback BJ, Dyce D, Bundy H. Trypsin, trypsinogen, and trypsin inhibitor in human pancreatic juice: mechanism for pancreatitis associated with hyperparathyroidism. Am J Med 1960; 29: 424-433
• 7 Cope O, Culver PJ, Mixter CG. et al. Pancreatitis, a diagnostic clue to hyperparathyroidism. Ann Surg 1957; 145: 857-863
• 8 Felderbauer P, Karakas E, Fendrich V. et al. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene. Am J Gastroenterol 2008; 103: 368-374
• 9 Prinz RA, Aranha GV. The association of primary hyperparathyroidism and pancreatitis. Am Surg 1985; 51: 325-329
• 10 Banks PA, Bollen TL, Dervenis C. et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-111
• 11 Bhansali A, Masoodi SR, Reddy KS. Primary hyperparathyroidism in north India: a description of 52 cases. Ann Saudi Med 2005; 25: 29-35
• 12 Bahrami A. Primary hyperparathyroidism in Iran: A review. Int J Endocrinol Metab 2008; 1: 50-57
• 13 Lin Zhao, Jian-min Liu, Xiao-Yan He. et al. The changing clinical patterns of primary hyperparathyroidism in chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab 2013; 98: 721-728
• 14 Eufrazino C, Veras A, Bandeira F. Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of Recife, Brazil. Clin Med Insights: Endocrinol Diabetes 2013; 6: 69-74
• 15 Vestergaard P, Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ 2003; 327: 530-534
• 16 Dubost C, Jehanno C, Poirier A. et al. Is there a risk of acute pancreatitis after parathyroidism?. Nouv Presse Med 1980; 9: 3281
• 17 London NJ, Lloyd DM, Pearson H. et al. Pancreatitis after parathyroidectomy. Br J Surg 1986; 73: 766-767
• 18 Ramachandran R, Nair GC, Babu MJ. et al. “Acute pancreatitis and primary hyperparathyroidism: Effect of parathyroidectomy”. Formos J Surg 2018; 51: 219-222
• 19 Carnaille B, Oudar C, Pattou F. et al. Pancreatitis and primary hyperparathyroidism: Forty cases. Aust N Z J Surg 1998; 68: 117-119
• 20 Jacob JJ, John M, Thomas N. et al. Does hyperparathyroidism cause pancreatitis? A South Indian experience and a review of published work. ANZ J Surg 2006; 76: 740-744
• 21 Arya AK, Bhadada SK, Mukherjee S. et al. Frequency & predictors of pancreatitis in symptomatic primary hyperparathyroidism. Indian J Med Res 2018; 148: 721-727
• 22 Yadav SK, Mishra SK, Mishra A. Changing Profile of Primary Hyperparathyroidism Over Two and Half Decades: A Study in Tertiary Referral Center of North India. World J Surg 2018; 42: 2732-2737
• 23 Ryzen E, Rude RK. Low intracellular magnesium in patients with acute pancreatitis and hypocalcemia. West J Med 1990; 152: 145-148
• 24 Han GY, Wang O, Xing XP. et al. The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis. Zhonghua Nei Ke Za Zhi 2009; 48: 729-733
• 25 Trabulus S, Oruc M, Ozgun E. et al. The Use of Low-Calcium Hemodialysis in the Treatment of Hypercalcemic Crisis. Nephron 2018; 139: 319-331
• 26 Eremkina A, Krupinova J, Dobreva E. et al. Denosumab for management of severe hypercalcemia in primary hyperparathyroidism. Endocr Connect 2020; 9: 1019-1027